Main funders

The Backbone of Innovation: Public Funding for Science

Public funding serves as the backbone of scientific innovation, enabling researchers to delve into the unknown and uncover transformative discoveries.

Mittelbrunn Lab is mostly funded by European, National and Regional public funders, like European Research Council, The Spanish National Research Agency (AEI), and the Comunidad de Madrid.

Age-associated T cells in Gut-Brain Axis

IP: Maria Mittelbrunn

Funding Entity

Agencia Estatal de Investigación

Financing

455.000 €

Duration of the contract

2024-2026

Contract/Project file

PID2022 1411690B-100 Gut-To-Brain

Energizing the failing heart

Coordinador: Mahmoud Abdellatif

Funding Entity

Agencia Estatal de Investigación

Financing

1.159.000 €

Duration of the contract

2024-2026

Contract/Project file

ERA4Health – CARDINNOV Ener-LIGHT

Letting up senescence and inflammaging through T cells

IP: Maria Mittelbrunn

Funding Entity

European Research Council

Financing

1.999.989 €

Duration of the contract

2023-2028

Contract/Project file

ERC CoG 101044248 Let T Be

Estrategias nutricionales de precisión para reactivar el sistema inmune deteriorado como consecuencia de la edad, la obesidad o la quimioterapia

IP: Ana Ramírez y Maria Mittelbrunn

Funding Entity

Comunidad de Madrid

Financing

616.730 €

Duration of the contract

2022-2024

Contract/Project file

CAM-Y2020/BIO-6350 NutriSIon

Cellular Metabolism as a New Therapeutic Target to Prevent Multimorbidity and Cardiovascular Diseases

IP: María Mittelbrunn Herrero

Funding Entity

Instituto de Salud Carlos III (co-financiado por fondos FEDER)

Financing

148.000 €

Duration of the contract

2020-2022

Contract/Project file

PI19/00855

Endolysosomal Mitochondria Crosstalk in Cell and Organism Homeostasis

IP: María Mittelbrunn Herrero

Funding Entity

European Research Council

Financing

1.498.000€

Duration of the contract

2017-2022

Contract/Project file

ERC StG 715322 EndoMitTalk

Alterations in the Immune System and their Role in Age-Associated Diseases

IP: María Mittelbrunn Herrero

Funding Entity

Instituto de Salud Carlos III

Financing

151.000 €

Duration of the contract

2017-2019

Contract/Project file

PI16/02188

Exosomes as Therapeutic Tool to Mediate Cardioprotection

IP: María Mittelbrunn Herrero

Funding Entity

Instituto de Salud Carlos III (co-financiado por fondos FEDER)

Financing

121.500 €

Duration of the contract

2015-2017

Contract/Project file

CP14/0219

Donate

With your support and that of other generous donors, Mittelbrunn´s Lab will have the necessary tools, personnel, and resources to spearhead the battle against age-associated diseases and conditions. Together, we can promote healthy aging and harness the power of the immune system to extend longevity.